Inactive Instrument
Mymetics Corporation Share Price Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 439K 384K 354K 329K 624K 41.85M 632K 4.24M 1.65M 20.54M 1.65M 1.61M 71.23M | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 72.12M 63.17M 58.18M 54M 103M 6.88B 104M 696M 271M 3.38B 271M 265M 11.71B | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 18/11/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| -2.14% | +3.51% | +74.50% | +131.10% | 59.1B | |
| -0.93% | +4.05% | +73.64% | +90.53% | 55.19B | |
| -2.81% | +0.64% | -13.80% | -10.31% | 24.67B | |
| +0.66% | +7.21% | +15.82% | +455.07% | 24.19B | |
| +0.64% | +14.41% | +44.27% | -3.20% | 19.69B | |
| -2.19% | +6.34% | +39.72% | -29.60% | 17.56B | |
| +3.58% | +25.11% | +196.41% | +363.46% | 16.22B | |
| +4.91% | +25.24% | +44.61% | - | 14.84B | |
| -1.05% | +1.92% | +25.27% | +186.19% | 14.04B | |
| Average | -0.96% | +8.39% | +55.60% | +147.90% | 27.28B | |
| Weighted average by Cap. | -0.57% | +6.43% | +58.17% | +136.24% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 430K 377K 347K 322K 611K 41.02M 620K 4.15M 1.62M 20.13M 1.61M 1.58M 69.81M | 1.03M 900K 829K 770K 1.46M 98.06M 1.48M 9.93M 3.86M 48.13M 3.86M 3.78M 167M |
| Net income | -4.73M -4.14M -3.82M -3.54M -6.73M -451M -6.82M -45.67M -17.77M -221M -17.76M -17.37M -768M | -4.8M -4.21M -3.88M -3.6M -6.83M -458M -6.92M -46.4M -18.06M -225M -18.04M -17.65M -780M |
| Net Debt | 67.1M 58.77M 54.13M 50.24M 95.41M 6.4B 96.7M 648M 252M 3.14B 252M 246M 10.89B | 71.68M 62.78M 57.82M 53.67M 102M 6.84B 103M 692M 269M 3.36B 269M 263M 11.64B |
Employees
-
Choose MarketScreener 
